摘要
目的探讨小细胞肺癌(yn)、嗜 铬蛋白(CgA)表达水平检测的临床意义。 方法 收集2015年3月-2017年3月在我院经 病理证实的45例SCLC患者及50例非小细 胞肺癌(NSCLC)患者,术前均行CT检查, 并采用免疫组化法检测癌组织及癌旁组 织中神经内分泌标志物Syn、CgA表达情 况。结果 SCLC胸腔积液、纵膈淋巴结 融合等CT征象出现比例分别为44.44%、 71.11%,明显高于NSCLC组的20.00%、 16.00%(P<0.05),而两组在心包积液、 胸膜转移、远处转移、大血管受侵等其 他CT征象出现比例上差异无统计学意义 (P>0.05)。Syn、CgA在SCLC中阳性表达 率为86.67%、53.33%,明显高于它们在 NSCLC中阳性表达率(16.00%、4.00%),差 异均有统计学意义(P<0.05)。在肺癌诊断 中,CT联合Syn、CgA检查鉴别SCLC的敏 感度、特异度、准确度分别为93.33%、 94.00%、93.68%,均明显优于单一检查, 差异有统计学意义(P<0.05)。结论 Syn、 CgA在SCLC与NSCLC中表达有明显差异,联 合CT扫描有助于提高SCLC的鉴别诊断水 平。
Objective To investigate the clinical significance of CT scan and the detection of expression levels of synaptophysin (Syn) and chromogranin (CgA) in cancer tissues of patients with small cell lung cancer (SCLC). Methods Forty-five patients with SCLC and fifty patients with non-small cell lung cancer (NSCLC) pathologically confirmed in the hospital from March 2015 to March 2017 were selected. All patients underwent CT examination before operation. The expression of neuroendocrine markers Syn and CgA in cancer tissues and adjacent tissues was detected by immunohistochemistry. Results The incidence rates of CT signs pleural effusion and mediastinal lymph node fusion in SCLC group (44.44% and 71.11%) were significantly higher than those in NSCLC group (20.00% and 16.00%) (P<0.05). However, there was no significant difference between the two groups in the other CT signs such as pericardial effusion, pleural metastasis, distant metastasis and macrovascular invasion (P>0.05). The positive expression rates of Syn and CgA in SCLC group (86.67% and 53.33%) were significantly higher than those in NSCLC group (16.00% and 4.00%) (P<0.05). The sensitivity, specificity and accuracy of CT combined with Syn and CgA in the diagnosis of SCLC (93.33%, 94.00% and 93.68%) were significantly better than those of single test (P<0.05). Conclusion The expression of Syn and CgA in SCLC and NSCLC are significantly different. Combined use of CT scan can help to improve the differential diagnosis of SCLC.
【关键词】小细胞肺癌;计算机体层成像;突触素;嗜铬蛋白
【中图分类号】R734.2
【文献标识码】A
【DOI】10.3969/j.issn.1672-5131.2018.09.004
前言
肺癌是临床最常见恶性肿瘤之一,发病率及死亡率均居于所有恶 性肿瘤之首,且呈逐年增高趋势[1]。研究显示,I期肺癌术后10年生存 率超过90%,因此,早期诊断及治疗是提高患者生存率之关键[2]。小细 胞肺癌(small cell lung cancer,SCLC)虽仅占肺癌的15%~20%,但 其细胞分化差、转移早、恶性程度高,较之非小细胞肺癌(no-small cell lung cancer,NSCLC),病情进展更为迅速,预后更差,受到越来 越多关注[3]。目前,CT是肺癌诊断的常用影像学检查方法,但其易受 检查者主观因素影响,存在较高假阳性率、假阴性率。近年来,神经 内分泌标志物对临床诊断的价值引起临床广泛重视。研究显示,突触 素(synaptophysin,Syn)、嗜铬蛋白(chromogranin A,CgA)在SCLC中 有着较高表达[4]。本研究采用免疫组化法检测检测Syn、CgA在SCLC、 NSCLC中的表达,探讨其联合CT诊断SCLC的临床价值,现报告如下。
中国CT和MRI杂志
第16卷, 第 9 期
2018年09月
相关文章